Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Acquired angioedema type 2 (AAE2) is a type of acquired angioedema (AAE) characterized by acute edema in subcutaneous tissues, viscera and/or the upper airway.
Biomarker and diagnostic research for acquired angioedema type 2 has been reported in the published literature.
No clinical trials have been registered for acquired angioedema type 2.
7 publications have been identified in PubMed for acquired angioedema type 2. Research spans Basic Science / Preclinical (33%), Diagnostic / Biomarker (17%), and Review / Meta-Analysis (17%).
Palestra F (2026). [PMID: 41784098](https://pubmed.ncbi.nlm.nih.gov/41784098/). *J Investig Allergol Clin Immunol*. [Basic Science / Preclinical]
Tarsitano M (2026). [PMID: 41752838](https://pubmed.ncbi.nlm.nih.gov/41752838/). *Life (Basel)*. [Gene Therapy / Novel Therapeutics]
Bernstein JA (2025). [PMID: 39944300](https://pubmed.ncbi.nlm.nih.gov/39944300/). *J Allergy Clin Immunol Glob*. [Diagnostic / Biomarker]
Ferrara AL (2025). [PMID: 38935036](https://pubmed.ncbi.nlm.nih.gov/38935036/). *Allergy*. [Basic Science / Preclinical]
Alvarado-Carrillo DL (2025). [PMID: 41037711](https://pubmed.ncbi.nlm.nih.gov/41037711/). *Rev Alerg Mex*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:44 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about acquired angioedema type 2